Abstract
Cells respond to stress by coordinating proliferative and metabolic pathways. Starvation restricts cell proliferative (glycolytic) and activates energy productive (oxidative) pathways. Conversely, cell growth and proliferation require increased glycolytic and decreased oxidative metabolism levels1. E2F transcription factors regulate both proliferative and metabolic genes2,3. E2Fs have been implicated in the G1/S cell-cycle transition, DNA repair, apoptosis, development and differentiation2,3,4. In pancreatic β-cells, E2F1 gene regulation facilitated glucose-stimulated insulin secretion5,6. Moreover, mice lacking E2F1 (E2f1−/−) were resistant to diet-induced obesity4. Here, we show that E2F1 coordinates cellular responses by acting as a regulatory switch between cell proliferation and metabolism. In basal conditions, E2F1 repressed key genes that regulate energy homeostasis and mitochondrial functions in muscle and brown adipose tissue. Consequently, E2f1−/− mice had a marked oxidative phenotype. An association between E2F1 and pRB was required for repression of genes implicated in oxidative metabolism. This repression was alleviated in a constitutively active CDK4 (CDK4R24C) mouse model or when adaptation to energy demand was required. Thus, E2F1 represents a metabolic switch from oxidative to glycolytic metabolism that responds to stressful conditions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Warburg, O. Ueber den Stoffwechsel der Tumoren (Constable, 1930).
Dimova, D. K. & Dyson, N. J. The E2F transcriptional network: old acquaintances with new faces. Oncogene 24, 2810–2826 (2005).
Sardet, C., Le Cam, L., Fabbrizio, E. & Vidal, M. E2Fs and the retinoblastoma protein family. Prog. Gene Exp. 2, 1–62 (1997).
Fajas, L. et al. E2Fs regulate adipocyte differentiation. Dev. Cell 3, 39–49 (2002).
Annicotte, J. S. et al. The CDK4–pRB–E2F1 pathway controls insulin secretion. Nat. Cell Biol. 11, 1017–1023 (2009).
Fajas, L. et al. Impaired pancreatic growth, β cell mass, and β cell function in E2F1(−/−) mice. J. Clin. Invest. 113, 1288–1295 (2004).
Rane, S. G. et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in β-islet cell hyperplasia. Nat. Genet. 22, 44–52 (1999).
Frolov, M. V. & Dyson, N. J. Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173–2181 (2004).
Hallstrom, T. C., Mori, S. & Nevins, J. R. An E2F1-dependent gene expression program that determines the balance between proliferation and cell death. Cancer Cell 13, 11–22 (2008).
Freedman, J. A., Chang, J. T., Jakoi, L. & Nevins, J. R. A combinatorial mechanism for determining the specificity of E2F activation and repression. Oncogene 28, 2873–2881 (2009).
Puigserver, P. et al. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92, 829–839 (1998).
Schiaffino, S. & Reggiani, C. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiol. Rev. 76, 371–423 (1996).
Gollnick, P. D., Armstrong, R. B., Saubert, C. W. T., Piehl, K. & Saltin, B. Enzyme activity and fiber composition in skeletal muscle of untrained and trained men. J. Appl. Physiol. 33, 312–319 (1972).
Wang, Y. X. et al. Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2, e294 (2004).
Calabria, E. et al. NFAT isoforms control activity-dependent muscle fiber type specification. Proc. Natl Acad. Sci. USA 106, 13335–13340 (2009).
Lin, J., Puigserver, P., Donovan, J., Tarr, P. & Spiegelman, B. M. Peroxisome proliferator-activated receptor γ coactivator 1β (PGC- 1β), a novel PGC-1-related transcription coactivator associated with host cell factor. J. Biol. Chem. 277, 1645–1648 (2002).
Seth, A. et al. The transcriptional corepressor RIP140 regulates oxidative metabolism in skeletal muscle. Cell Metab. 6, 236–245 (2007).
Wallace, D. C. A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu. Rev. Genet. 39, 359–407 (2005).
Chong, J. L. et al. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature 462, 930–934 (2009).
Dali-Youcef, N. et al. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc. Natl Acad. Sci. USA 104, 10703–10708 (2007).
Lagouge, M. et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC- 1α. Cell 127, 1109–1122 (2006).
Mir, L. M. et al. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl Acad. Sci. USA 96, 4262–4267 (1999).
Annicotte, J. et al. Pancreatic-duodenal homeobox 1 regulates expression of liver receptor homolog 1 during pancreas development. Mol. Cell Biol. 23, 6713–6724 (2003).
Mensink, M. et al. Improved skeletal muscle oxidative enzyme activity and restoration of PGC- 1α and PPAR β/δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. Int. J. Obes. 31, 1302–1310 (2007).
Handschin, C. et al. PGC- 1α regulates the neuromuscular junction program and ameliorates Duchenne muscular dystrophy. Genes Dev. 21, 770–783 (2007).
Casas, F. et al. Overexpression of the mitochondrial T3 receptor p43 induces a shift in skeletal muscle fiber types. PLoS ONE 3, e2501 (2008).
Sarruf, D. A. et al. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor γ. Mol. Cell Biol. 25, 9985–9995 (2005).
Fajas, L. et al. The retinoblastoma-histone deacetylase 3 complex inhibits the peroxisome proliferator-activated receptor γ and adipocyte differentiation. Dev. Cell 3, 903–910 (2002).
Aguilar, V. et al. S6 kinase deletion suppresses muscle growth adaptations to nutrient availability by activating AMP kinase. Cell Metab. 5, 476–487 (2007).
Annicotte, J. S. et al. Peroxisome proliferator-activated receptor γ regulates E-cadherin expression and inhibits growth and invasion of prostate cancer. Mol. Cell Biol. 26, 7561–7574 (2006).
Acknowledgements
We thank M. Barbacid, B.M. Spiegelman, C. Sardet and L. Le Cam for the gift of materials and D. Greuet, C. Henriquet, S. Hure and J. Teyssier for their technical help. The authors are grateful to C. Cazevieille from Centre de Ressources en Imagerie Cellulaire de Montpellier for her technical assistance, data interpretation and ultrastructural evaluations. We are indebted to the RHEM network (Réseau d’Histologie Expérimentale de Montpellier, IFR122, France) for histology and, in particular, for tissue and slide preparations. Members of the Fajas laboratory are acknowledged for support and discussions. This work was supported by grants from Agence Nationale pour la Recherche (ANR genopath), INSERM-Association pour la Recherche sur le Diabète (PNR Diabète), Association Française des Diabétiques, Société Francophone du Diabète, Association pour la Recherche contre le Cancer, Fondation pour la Recherche Médicale, Ligue Contre le Cancer, European Research Council, National Institutes of Health, Swiss National Science Foundation and EPFL. E.B. was supported by a grant from the Ministère de l’Enseignement Supérieur et de la Recherche; C.C. was supported by a grant from the Agence Nationale pour la Recherche.
Author information
Authors and Affiliations
Contributions
J-S.A. and L.F. designed the study. E.B., J-S.A., S.L., V.A., V.F., C. Chavey and C. Clapé carried out the experiments. F.A., F.C. and J.A. provided reagents and data. J-S.A. and L.F. wrote the manuscript.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Information
Supplementary Information (PDF 1874 kb)
Supplementary Table 1
Supplementary Information (XLSX 12 kb)
Rights and permissions
About this article
Cite this article
Blanchet, E., Annicotte, JS., Lagarrigue, S. et al. E2F transcription factor-1 regulates oxidative metabolism. Nat Cell Biol 13, 1146–1152 (2011). https://doi.org/10.1038/ncb2309
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb2309
This article is cited by
-
M1BP is an essential transcriptional activator of oxidative metabolism during Drosophila development
Nature Communications (2023)
-
Chaperone-mediated autophagy promotes PCa survival during ARPI through selective proteome remodeling
Oncogene (2023)
-
Targeting the E2F1/Rb/HDAC1 axis with the small molecule HR488B effectively inhibits colorectal cancer growth
Cell Death & Disease (2023)
-
Knockout of ICAT in Adipose Tissue Alleviates Fibro-inflammation in Obese Mice
Inflammation (2023)
-
NCAPD3 enhances Warburg effect through c-myc and E2F1 and promotes the occurrence and progression of colorectal cancer
Journal of Experimental & Clinical Cancer Research (2022)